Company Profile

EyeNexo LLC (AKA: Eyephone LLC)
Profile last edited on: 3/26/20      CAGE: 78TU6      UEI: SCTQD2V8G8T5

Business Identifier: Improving access to quality eye care with smartphone apps
Year Founded
2014
First Award
2015
Latest Award
2019
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

90 Canal Street 400
Boston, MA 02114
Location: Single
Congr. District: 08
County: Suffolk

Public Profile

Eyephone (being renamed EYENexo? (2020) is working on devleoping digital tools to improve quality eye care. Structured around improving access to accurate eye care through creative mobile app engineering and prototypes – principals of the firm are leveraging established expertise in the eye care field to bring the power and the creativity of smartphone engineering and mobile technology to ophthalmic treatment. EyeTurn is an App for Android systems that measures the eyes alignment for patients with strabismus. Eyephone wants to increase accessibility to ophthalmic treatments by reducing prices and bringing innovative solutions to the doctors and patients. The goal of the company is to use the accessibility and power of the smartphones to provide fast and accurate measurements. The firm use smartphones to create a reliable network between expert eye doctors and patients via telemedicine

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2019 1 NIH $273,364
Project Title: Head Mounted Smartphone System for Remote Treatment of Convergence Insufficiency
2018 2 NIH $1,164,798
Project Title: Mobile Medical Application for Cost-Effective Strabismus Screening

Key People / Management

  Matteo Tomasi -- CEO

  Gang Luo

  David Titus -- VP of Business Development and Marketing

Company News

There are no news available.